Close

Clinical Trials

GlycoMimetics Reports Top-line Results From Pfizers Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease

GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did not meet its primary or key secondary efficacy endpoints. The objective of the trial was to...

Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data

Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing with additional patients for device and cell transplantation. Sernova announced on July 3, 2019, a case study describing preliminary data...

Carolina Partners Clinical Research Institute, LLC, Announces Partnership to Provide Research as Care

Carolina Partners Clinical Research Institute, LLC, North Carolina’s largest outpatient mental and behavioral health practice, has partnered with Elligo Health Research, a healthcare-enabling research organization, to further expand its clinical research program. The partnership makes it possible for Carolina...

Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in amyotrophic lateral sclerosis

Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases announces that it has completed enrollment in its phase 3 trial evaluating arimoclomol for the treatment of Amyotrophic Lateral Sclerosis (ALS) ahead of schedule....

AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio Including Extensive Programs in China

Median Technologies, The Imaging Phenomics Company and AG Mednet have renewed their partnership to use AG Mednet’s global infrastructure for the collection, QC and delivery of medical images and ancillary data in support current and future clinical trials and...

Clinerion continues expansion of Patient Network Explorer coverage in South America by partnering with B-TRIALS in Chile.

The Chilean company B-TRIALS, a specialist in providing tools and solutions in the health area, will be responsible for the expansion of Clinerion in Chile. This will give patients in Chile quicker and better access to innovative medical treatments...

SpringWorks and GSK sign clinical trial collaboration agreement

SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma. Under the clinical trial collaboration agreement, GSK will sponsor and conduct an adaptive Phase...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read